Home LiteratureArticle Details
PMID: 26231267 Published · ppublish English

Hemispherectomy for Hemimegalencephaly Due to Tuberous Sclerosis and a Review of the Literature.

Pediatric neurology ·Vol. 53 ·No. 5 ·2016-08-03

Cuddapah Vishnu Anand, Thompson Matthew, Blount Jeffrey, Li Rong, Guleria Saurabh, Goyal Monisha

Abstract

Hemimegalencephaly with tuberous sclerosis complex is an uncommon association, usually associated with intractable seizures that begin in the neonatal period or early infancy. Typically, the seizures are managed with medications until the patient is older when surgical treatment is considered safe.,We describe a 7-week-old infant with tuberous sclerosis (TSC1 mutation) and hemimegalencephaly who underwent a functional hemispherectomy for status epilepticus. No clinical seizures have occurred since surgery nearly 5 years ago and subsequent weaning of antiepileptic drugs 3 years ago. This is one of the youngest patients with tuberous sclerosis complex treated with a hemispherectomy and one of seven patients described in the literature.,Our patient, along with previously reported cases, suggests that a hemispherectomy is a viable option in the very young. With evolution of this surgical process since its inception nearly 6 decades ago, it may now be performed safely in early infancy, engendering the possibility of seizure freedom in most and thus optimizing neurodevelopmental outcome.

Keywords
Neurocutaneous syndrome epilepsy surgery functional hemispherectomy hemispherectomy intractable epilepsy tuberous sclerosis
Article Info
Journal
Pediatric neurology
Abbr.
Pediatr Neurol
Published
2016-08-03
Indexed
2015-10-18
Updated
2016-11-25
Language
English
Country/Region
United States
NLM ID
8508183
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]